Clinical Trial Update: Safety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial results evaluate the safety and efficacy of vortioxetine (Lu AA21004) in adults with major depressive disorder. The study has completed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: Takeda | Conditions: Depressive Disorder, Major | Phase 3 | Status: COMPLETED | Results posted: 2013-12-18